Lifileucel: FDA-approved T-cell therapy for melanoma

被引：3
|
作者：
Kwong, Mei Li M. [1 ]
Yang, James C. [1 ]
机构：
[1] NCI, Surg Branch, NIH, Bethesda, MD 20814 USA
来源：
ONCOLOGIST | 2024年 / 29卷 / 08期
关键词：
TUMOR-INFILTRATING LYMPHOCYTES; METASTATIC MELANOMA; ADOPTIVE TRANSFER; IMMUNOTHERAPY; INTERLEUKIN-2; EFFICACY; CANCER;
D O I：
10.1093/oncolo/oyae136
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This commentary reports on the history of tumor-infiltrating lymphocytes (TIL) for adoptive cell therapy and where TIL fits into the treatment options for metastatic melanoma.
引用
收藏
页码：648 / 650
页数：3
相关论文
共 50 条
  • [1] FDA-approved CAR T-cell Therapy: A Decade of Progress and Challenges
    Ong, Melissa Z.
    Kimberly, Sharon A.
    Lee, Wen-Hwei
    Ling, Marcus
    Lee, Michael
    Tan, Ke-Wei
    Foo, Jhi-Biau
    Yow, Hui-Yin
    Sellappans, Renukha
    Hamzah, Sharina
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2024, 25 (11) : 1377 - 1393
  • [2] Exploring potential FDA-approved components for DMSO-free T-cell cryopreservation solutions
    Trudel, J.
    Pasley, S.
    Cho, J.
    Zylberberg, C.
    CYTOTHERAPY, 2020, 22 (05) : S160 - S160
  • [3] First FDA-Approved Gene Therapy for Hemophilia
    Larkin, Howard
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (01): : 14 - 14
  • [4] Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma
    Cho, Su Min
    Esmail, Abdullah
    Raza, Ali
    Dacha, Sunil
    Abdelrahim, Maen
    CANCERS, 2022, 14 (11)
  • [5] FDA-APPROVED INDICATIONS
    ANDERSON, DA
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1984, 41 (11): : 2328 - 2328
  • [6] FDA-Approved Chimeric Antigen Receptor (CAR)-T Cell Therapy for Different Cancers-A Recent Perspective
    Thirumalaisamy, R.
    Vasuki, S.
    Sindhu, S. M.
    Mothilal, T. M.
    Srimathi, V.
    Poornima, B.
    Bhuvaneswari, M.
    Hariharan, Mohan
    MOLECULAR BIOTECHNOLOGY, 2025, 67 (02) : 469 - 483
  • [7] FDA-Approved Antibacterials and Echinocandins
    Al Musaimi, Othman
    ANTIBIOTICS-BASEL, 2025, 14 (02):
  • [8] Tecartus First CAR T-Cell Therapy FDA Approved for Patients with Mantle-Cell Lymphoma
    Marks, Peter
    AMERICAN HEALTH AND DRUG BENEFITS, 2020, 13 (05): : 215 - 215
  • [9] EVALUATION OF REGULATORY PARTICULARS AND CMC REVIEW ISSUES FOR FDA-APPROVED CELL THERAPY PRODUCTS
    McCord, A.
    CYTOTHERAPY, 2024, 26 (06) : S118 - S118
  • [10] Stem cell therapy for stroke: preclinical evidence and an update on FDA-approved clinical trials
    Borlongan, Cesar V.
    NEUROREPORT, 2014, 25 (03) : 140 - 140
12345